ArticleMicrobial cell factories2025
Growth-independent CLA production by Bifidobacterium breve JKL2022 and the potential transcriptional regulatory role of TetR in linoleic acid isomerase expression.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundMicrobial production of conjugated linoleic acid (CLA) has garnered wide attention for the possibility to increase the CLA content in food products, therefore achieving higher concentrations of beneficial compounds for consumers. However, this approach has only been done using metabolically active cells, particularly in Bifidobacterium spp., thus being a major limitation given the anaerobic and fastidious nature of bifidobacteria. In this study, we aimed to investigate the capacity of Bifidobacterium breve JKL2022 (KACC81214BP) to convert free linoleic acid (LA) into CLA using growing cells and postbiotic preparations (washed cells and crude protein extracts) as catalysts.
resultsBifidobacterium breve JKL2022 demonstrated high CLA production as early as 6 h and continued to increase until 12-15 h of incubation. Moreover, CLA production was observed in JKL2022 washed cells (97.42 ± 3.64%) and crude protein fractions (33.87 ± 4.05%- 103.65 ± 2.70%) obtained after cell lysis, highlighting its superior CLA-converting activity compared to the B. breve JCM strains. In vitro CLA reaction conditions were optimal at pH 7.0, following the first-order kinetics within the first 5 min of reaction, and the extraction efficiency of the isopropanol-hexane protocol increased after adjusting the pH to 5.0-5.5. Finally, RT-qPCR and in silico analysis revealed a strong correlation between the expression levels of lai (JKL2022_00014) and tetR (JKL2022_00217) genes, suggesting the potential role of TetR in upregulating the lai gene expression in JKL2022 that could explain the LA conversion in washed JKL2022 cells.
conclusionsThe ability of B. breve JKL2022 strain to convert free LA to CLA during growth, as well as using washed cells and crude protein extracts, suggests strain specificity and superior enzymatic activity. In addition to its potential application as a probiotic strain with CLA-enhancing properties, washed JKL2022 cells or crude protein extracts can be developed as postbiotic preparations for the same purpose.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.